The outpatient total hip arthroplasty: A paradigm change

Bone and Joint Journal

Volumn 100B, Issue 1, 2018, Pages 31-35

  Berend, K R ^a   Lombardi, A V ^a   Berend, M E ^b   Adams, J B ^a   Morris, M J ^a  

^a Joint Implant Surgeons   (United States)

^b Midwest Centre for Joint Replacement   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMBULATORY SURGERY; ANALGESIA; ARTICLE; ASTHMA; BODY MASS; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONSERVATIVE TREATMENT; CONSTIPATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DIVERTICULITIS; FEMALE; HEART ARRHYTHMIA; HEMATOMA; HOSPITALIZATION; HUMAN; HYPOXIA; ILEUS; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL RECORD; MIDDLE AGED; OPERATION DURATION; OUTPATIENT; PERIPROSTHETIC FRACTURE; POLLAKISURIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK ASSESSMENT; SEPTICEMIA; SHOULDER DISLOCATION; SLEEP DISORDERED BREATHING; SURGICAL PATIENT; SURGICAL RISK; THORAX PAIN; THROMBOEMBOLISM; URINARY TRACT INFECTION; URINE RETENTION; VALVULAR HEART DISEASE; VOMITING; AGED; HIP REPLACEMENT; OUTCOME ASSESSMENT; PROCEDURES; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY SURGICAL PROCEDURES; ARTHROPLASTY, REPLACEMENT, HIP; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 85040005695     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.100B1.BJJ-2017-0514.R1     Document Type: Article

References (12)

1. Pollock M, Somerville L, Firth A, Lanting B. Outpatient total hip arthroplasty, total knee arthroplasty, and unicompartmental knee arthroplasty: a systematic review of the literature JBJS Rev 2016;4:01874474-201612000.
2. Bradley B, Middleton S, Davis N, et al. Discharge on the day of surgery following unicompartmental knee arthroplasty within the United Kingdom NHS. Bone Joint J 2017;99-B:788-792.
3. Mason JB. The new demands by patients in the modern era of total joint arthroplasty: a point of view. Clin Orthop Relat Res 2008;466:146-152.
4. Berend KR, Lombardi AV Jr. Multimodal venous thromboembolic disease prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin. Am J Orthop (Belle Mead NJ) 2006;35:24-29.
5. Lee QJ, Chang WY, Wong YC. Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty. J Arthroplasty 2017;32:139-142.
6. Moskal JT, Capps SG. Meta-analysis of intravenous tranexamic acid in primary total hip arthroplasty. Orthopedics 2016;39:883-892.
7. Mirza AJ, Lombardi AV Jr, Morris MJ, Berend KR. A mini-anterior approach to the hip for total joint replacement: optimising results: improving hip joint replacement outcomes. Bone Joint J 2014;96-B(Supple A):32-35.
8. Courtney PM, Rozell JC, Melnic CM, Lee GC. Who should not undergo short stay hip and knee arthroplasty? Risk factors associated with major medical complications following primary total joint arthroplasty. J Arthroplasty 2015;30(suppl):1-4.
9. Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941;2:281-284.
10. Goyal N, Chen AF, Padgett SE, et al. Otto Aufranc Award: A multicenter, randomized study of outpatient versus inpatient total hip arthroplasty. Clin Orthop Relat Res 2017;475:364-372.
11. Hartog YM, Mathijssen NM, Vehmeijer SB. Total hip arthroplasty in an outpatient setting in 27 selected patients. Acta Orthop 2015;86:667-670.
12. Aynardi M, Post Z, Ong A, Orzco F, Sukin DC. Outpatient surgery as a means of cost reduction in total hip arthroplasty: a case-control study. HSS J 2014;10:252-255.